Document: Annex III - Written responses to list of issues - molecule-independent device bridging approach (MIDBA)-2025/10/24

Document: Annex II - Initial Qualification Opinion List of Issues - molecule-independent device bridging approach (MIDBA)-2025/10/24

Document: Draft qualification opinion for molecule-independent device bridging approach (MIDBA)-2025/10/24

Document: Draft guideline on quality aspects of phage therapy medicinal products-2025/10/24

Document: Clinical Trial Information System (CTIS) structured data form - Notifications, Annual Safety Report (ASR) and results-2025/10/23

Document: Minutes of the COMP meeting 9-11 September 2025-2025/10/23

Page: Non-human primates in safety testing of human medicinal products and opportunities for 3Rs implementation - Scientific guideline-2025/10/23

Document: Reflection paper on non-human primates in safety testing of human medicinal products and opportunities for 3Rs implementation-2025/10/23

Document: Overview of (invented) names reviewed in September 2025 by the Name Review Group (NRG) adopted at the CHMP meeting of 16 October 2025-2025/10/23

Page: Website outages and upgrades-2025/10/23